Investment Portfolio      
NSGENE A/S
NsGene, a spin-out from NeuroSearch A/S, is focused on developing treatments for neurological diseases based on Factor Products and Encapsulated Cell Technology. NsGene has discovered and patented Neublastin, a neurotrophic factor that has been out-licensed to Biogen, Inc. for the treatment of the peripheral nervous system diseases.

www.nsgene.com